Core Laboratories N.V. (CLB) Stock Overview
Explore Core Laboratories N.V.’s financial performance, market position, analyst ratings, and future outlook.
Core Laboratories N.V. (CLB)
Key Financials
Key Financials
Market Cap
611.2M
P/E Ratio
20.90
EPS (TTM)
$0.61
ROE
0.11%
CLB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Core Laboratories N.V. (CLB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 43.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.55.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.90 and a market capitalization of 611.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.